◆ Kolon TissueGene = The Korea Exchange announced that it held a corporate review committee for Kolon TissueGene and decided to grant a one-year improvement period.


◆ Hans Biomed = Announced the decision to issue 15 billion KRW worth of bonds with warrants to raise operating funds.


◆ Huons = Decided on new facility investment worth 52.9 billion KRW, equivalent to 21.74% of equity capital.


◆ SL Bionics = Announced that The Stalla Co., Ltd. has filed a provisional injunction lawsuit to suspend the effectiveness of the shareholders' meeting resolution.


◆ Cellumed = Subsidiary BH Cell decided on a paid-in capital increase worth 7.2 billion KRW to raise operating funds.


◆ Joheun Saramdeul = Announced that 194 people including Choi Han-woo filed a lawsuit at the Seoul Western District Court to request permission to convene a shareholders' meeting.



◆ Intec Plus = Announced on the 31st that the semiconductor inspection equipment supply contract worth 6.3 billion KRW with Powertech Technology has been terminated.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing